Skip to content
Statistics

Image -

Statistics

Survival rates for men with metastatic prostate cancer
Marcus Westerberg/ JAMA Network Open
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By:
Marcus Westerberg/ JAMA Network Open
Copyright:
Marcus Westerberg/ JAMA Network Open
File format:
.jpg
Size:
3002 x 2312, 850 KB
Download

Topics

Categories

Contacts

Elin Bäckström

Press contact Press Officer Research Education +46-70-425 09 83

Linda Koffmar

Press contact Press Officer +46 (0)18-471 19 59

Sandra Gunnarsson

Press contact Press Officer +4673 469 75 92

Related content

Men with metastatic prostate cancer live longer thanks to new drugs

Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of ‘dual treatment’ since 2016. This is according to a register study of all Swedish men diagnosed between 2008 and 2020. The results are published in the medical journal JAMA Network open.

Uppsala University - quality, knowledge, and creativity since 1477

Founded in 1477, Uppsala University is the oldest university in Sweden. With more than 50,000 students and 7,500 employees in Uppsala and Visby, we are a broad university with research in social sciences, humanities, technology, natural sciences, medicine and pharmacology. Our mission is to conduct education and research of the highest quality and relevance to society on a long-term basis. Uppsala University is regularly ranked among the world’s top universities.

Uppsala University

Dag Hammarskjölds väg 7
BOX 256, 751 05 Uppsala
Sweden